Plus Therapeutics, Inc.
USD3.74
-0.16 (-4.10%)
CEO
Marc H. Hedrick
IPO Date
2001-07-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.78
Prev. Close
$3.90
Day Low
$3.59
Day High
$3.96
52W Low
$2.90
52W High
$23.50
Market Cap
$0.01B
Volume
0.22M
| 922 |
| $0.00 |
| 1 Jul 2026 | Guse Kyle | director | M-Exempt | Acquired | 922 | $0.00 |
| 1 Jul 2026 | Guse Kyle | director | M-Exempt | Disposed | 922 | $0.00 |
| 1 Jul 2026 | van Es-Johansson An | director | M-Exempt | Acquired | 922 | $0.00 |
| 1 Jul 2026 | van Es-Johansson An | director | M-Exempt | Disposed | 922 | $0.00 |
| 1 Jul 2026 | HEDRICK MARC H | director, officer: Chief Executive Officer | M-Exempt | Acquired | 6,387 | $0.00 |
| 1 Jul 2026 | HEDRICK MARC H | director, officer: Chief Executive Officer | M-Exempt | Acquired | 8,066 | $0.00 |
| 1 Jul 2026 | HEDRICK MARC H | director, officer: Chief Executive Officer | M-Exempt | Acquired | 1,986 | $0.00 |
| 1 Jul 2026 | HEDRICK MARC H | director, officer: Chief Executive Officer | M-Exempt | Disposed | 6,387 | $0.00 |